Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ZBIO

Zenas Biopharma Inc

May 29 • 04:00PM ET

18.40

-0.16 -0.86 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR NUVL BMRN RYTM INCY KRYS VKTX AXSM MDGL NBIX

| Held by: XBI VTI IWM VXF IWN IBB SCHA VTWO VFMO IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-9.10	Insider Own	49.61%	Shs Outstand	62.38M	Perf Week	-7.26%
Market Cap	1.16B	Forward P/E	-	EPS next Y	-4.73	Insider Trans	1.97%	Shs Float	31.81M	Perf Month	4.84%
Enterprise Value	796.17M	PEG	-	EPS next Q	-1.12	Inst Own	63.54%	Short Float	33.60%	Perf Quarter	-30.17%
Income	-425.15M	P/S	-	EPS this Y	43.01%	Inst Trans	21.81%	Short Ratio	15.98	Perf Half Y	-53.84%
Sales	0.00M	P/B	3.42	EPS next Y	1.66%	ROA	-78.63%	Short Interest	10.69M	Perf YTD	-49.33%
Book/sh	5.38	P/C	1.62	EPS next 5Y	21.09%	ROE	-137.11%	52W High	44.60 -58.74%	Perf Year	84.00%
Cash/sh	11.36	P/FCF	-	EPS past 3/5Y	-39.47% -	ROIC	-61.93%	52W Low	8.91 106.51%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.76% 7.49%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-128.73%	Oper. Margin	-	ATR (14)	1.36	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.94	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	45.26	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	11.94	EPS Q/Q	-81.27%	SMA20	-4.43%	Beta	-0.69	Target Price	42.12
Payout	-	Debt/Eq	1.05	Sales Q/Q	-100.00%	SMA50	-8.04%	Rel Volume	1.08	Prev Close	18.56
Employees	167	LT Debt/Eq	1.04	Earnings	May 13 BMO	SMA200	-25.15%	Avg Volume	668.76K	Price	18.40
IPO	Sep 13, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.96% -	Trades		Volume	724,639	Change	-0.86%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)